MEK drives cyclin D1 hyperelevation during geroconversion
- 12 July 2013
- journal article
- Published by Springer Science and Business Media LLC in Cell Death & Differentiation
- Vol. 20 (9), 1241-1249
- https://doi.org/10.1038/cdd.2013.86
Abstract
When the cell cycle becomes arrested, MTOR (mechanistic Target of Rapamycin) converts reversible arrest into senescence (geroconversion). Hyperexpression of cyclin D1 is a universal marker of senescence along with hypertrophy, beta-Gal staining and loss of replicative/regenerative potential (RP), namely, the ability to restart proliferation when the cell cycle is released. Inhibition of MTOR decelerates geroconversion, although only partially decreases cyclin D1. Here we show that in p21- and p16-induced senescence, inhibitors of mitogen-activated/extracellular signal-regulated kinase (MEK) (U0126, PD184352 and siRNA) completely prevented cyclin D1 accumulation, making it undetectable. We also used MEL10 cells in which MEK inhibitors do not inhibit MTOR. In such cells, U0126 by itself induced senescence that was remarkably cyclin D1 negative. In contrast, inhibition of cyclin-dependent kinase (CDK) 4/6 by PD0332991 caused cyclin D1-positive senescence in MEL10 cells. Both types of senescence were suppressed by rapamycin, converting it into reversible arrest. We confirmed that the inhibitor of CDK4/6 caused cyclin D1 positive senescence in normal RPE cells, whereas U0126 prevented cyclin D1 expression. Elimination of cyclin D1 by siRNA did not prevent other markers of senescence that are consistent with the lack of its effect on MTOR. Our data confirmed that a mere inhibition of the cell cycle was sufficient to cause senescence, providing MTOR was active, and inhibition of MEK partially inhibited MTOR in a cell-type-dependent manner. Second, hallmarks of senescence may be dissociated, and hyperelevated cyclin D1, a marker of hyperactivation of senescent cells, did not necessarily determine other markers of senescence. Third, inhibition of MEK was sufficient to eliminate cyclin D1, regardless of MTOR.Keywords
This publication has 72 references indexed in Scilit:
- Senescence-associated secretory phenotype favors the emergence of cancer stem-like cellsCell Death & Disease, 2012
- Hypoxia suppresses conversion from proliferative arrest to cellular senescenceProceedings of the National Academy of Sciences of the United States of America, 2012
- A set of miRNAs participates in the cellular senescence program in human diploid fibroblastsCell Death & Differentiation, 2011
- ERK Crosstalks with 4EBP1 to Activate Cyclin D1 Translation during Quinol-Thioether–Induced Tuberous Sclerosis Renal Cell CarcinomaToxicological Sciences, 2011
- DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretionJournal of Cell Science, 2011
- Paradoxical suppression of cellular senescence by p53Proceedings of the National Academy of Sciences of the United States of America, 2010
- F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damageNature, 2009
- c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycleOncogene, 2007
- p21Waf1/Cip1/Sdi1 mediates retinoblastoma protein degradationOncogene, 2007
- The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct MechanismsMolecular and Cellular Biology, 2006